Merck
HomeWebinars2021 Virtual PEG Symposium

2021 Virtual PEG Symposium



WEBINAR

This technical symposium is a unique opportunity to discover enabling technologies and today's trends in the broad field of pharmaceutical PEG applications, development, and processing.

Industry experts will present the latest progress in activated PEGs and conjugation chaired by Lisa McDermott from Merck.

During this symposium, you will:

  • Learn about the next generation of protein PEGylation and PEG analytics
  • Get perspectives on regulatory aspects for activated PEGs in pharmaceutical applications
  • Discuss and tackle today’s PEG challenges with your peers

Speakers

Lisa McDermott

Lisa McDermott

Merck

Director Process and Analytical Development

Lisa joined Merck in January 2010 as an analytical project lead, responsible for ADCs. She brings with her more than 25 years of experience in both organic synthesis and analytical sciences and has had the opportunity to contribute to many projects ranging from discovery to full development, but none has been as exciting as the emergence of ADCs. She also has an extensive chromatography background with experience in integrated LC/MS screening systems.

Lars Albermann, Ph.D.

Lars Albermann, Ph.D.

Merck

Head of Pharma Registration and Regulatory Projects

Tobias Haag, Ph.D.

Tobias Haag, Ph.D.

Merck

Head Process and Analytical Development, Schaffhausen

Marco Passafaro, Ph.D.

Marco Passafaro, Ph.D.

Merck

Senior Scientist, R&D Drug Delivery Compounds